These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1756536)

  • 1. Pharmacokinetics and biodistribution of a new anti-episialin monoclonal antibody 139H2 in ovarian-cancer-bearing nude mice.
    Molthoff CF; Pinedo HM; Schlüper HM; Boven E
    Cancer Immunol Immunother; 1991; 34(3):191-7. PubMed ID: 1756536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer.
    Molthoff CF; Pinedo HM; Schlüper HM; Nijman HW; Boven E
    Br J Cancer; 1992 May; 65(5):677-83. PubMed ID: 1586596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 131I-labelled anti-episialin 139H2 with cisplatin, cyclophosphamide or external-beam radiation for anti-tumor efficacy in human ovarian cancer xenografts.
    Molthoff CF; Pinedo HM; Schlüper HM; Rutgers DH; Boven E
    Int J Cancer; 1992 Apr; 51(1):108-15. PubMed ID: 1563830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of dose and schedule on the therapeutic efficacy of 131I-labelled monoclonal antibody 139H2 in a human ovarian cancer xenograft model.
    Molthoff CF; Pinedo HM; Schlüper HM; Boven E
    Int J Cancer; 1992 Feb; 50(3):474-80. PubMed ID: 1735615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of monoclonal antibodies 17-1A and 323/A3: the influence of the affinity on tumour uptake and efficacy of radioimmunotherapy in human ovarian cancer xenografts.
    Kievit E; Pinedo HM; Schlüper HM; Haisma HJ; Boven E
    Br J Cancer; 1996 Feb; 73(4):457-64. PubMed ID: 8595159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and specific targeting of monoclonal antibody A33 to a colon cancer xenograft in nude mice.
    Barendswaard EC; Scott AM; Divgi CR; Williams C; Coplan K; Riedel E; Yao TJ; Gansow OA; Finn RD; Larson SM; Old LJ; Welt S
    Int J Oncol; 1998 Jan; 12(1):45-53. PubMed ID: 9454885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of tumor-related factors of influence on the uptake of the monoclonal antibody 323/A3 in experimental human ovarian cancer.
    Kievit E; Pinedo HM; Schlüper HM; Haisma HJ; Boven E
    Int J Cancer; 1997 Apr; 71(2):237-45. PubMed ID: 9139849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immuno-PET of human colon xenograft- bearing BALB/c nude mice using 124I-CDR-grafted humanized A33 monoclonal antibody.
    Lee FT; Hall C; Rigopoulos A; Zweit J; Pathmaraj K; O'Keefe GJ; Smyth FE; Welt S; Old LJ; Scott AM
    J Nucl Med; 2001 May; 42(5):764-9. PubMed ID: 11337573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRI.
    Palm S; Enmon RM; Matei C; Kolbert KS; Xu S; Zanzonico PB; Finn RL; Koutcher JA; Larson SM; Sgouros G
    J Nucl Med; 2003 Jul; 44(7):1148-55. PubMed ID: 12843231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoscintigraphy of small-cell lung cancer xenografts with anti neural cell adhesion molecule monoclonal antibody, 123C3: improvement of tumour uptake by internalisation.
    Kwa HB; Wesseling J; Verhoeven AH; van Zandwijk N; Hilkens J
    Br J Cancer; 1996 Feb; 73(4):439-46. PubMed ID: 8595157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of radiolabelled F(ab')2 fragments of monoclonal antibodies in nude mice bearing intraperitoneally growing human ovarian cancer xenografts.
    Moseley KR; Battaile A; Knapp RC; Haisma HJ
    Int J Cancer; 1988 Sep; 42(3):368-72. PubMed ID: 3417365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human ovarian cancer xenografts in nude mice: characterization and analysis of antigen expression.
    Molthoff CF; Calame JJ; Pinedo HM; Boven E
    Int J Cancer; 1991 Jan; 47(1):72-9. PubMed ID: 1985883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperthermic modulation of radiolabelled antibody uptake in a human glioma xenograft and normal tissues.
    Schuster JM; Zalutsky MR; Noska MA; Dodge R; Friedman HS; Bigner DD; Dewhirst MW
    Int J Hyperthermia; 1995; 11(1):59-72. PubMed ID: 7714371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the DF3-P epitope in human ovarian carcinomas.
    Ichige K; Perey L; Vogel CA; Buchegger F; Kufe D
    Clin Cancer Res; 1995 May; 1(5):565-71. PubMed ID: 9816017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of circulating antigen on the biodistribution of the engineered human antibody hCTM01 in a nude mice model.
    Davies Q; Perkins AC; Frier M; Watson S; Lalani E; Symonds EM
    Eur J Nucl Med; 1997 Feb; 24(2):206-9. PubMed ID: 9021120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and microdistribution of polyethylene glycol-modified humanized A33 antibody targeting colon cancer xenografts.
    Deckert PM; Jungbluth A; Montalto N; Clark MA; Finn RD; Williams C; Richards EC; Panageas KS; Old LJ; Welt S
    Int J Cancer; 2000 Aug; 87(3):382-90. PubMed ID: 10897044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superior localisation and imaging of radiolabelled monoclonal antibody E48 F(ab')2 fragment in xenografts of human squamous cell carcinoma of the head and neck and of the vulva as compared to monoclonal antibody E48 IgG.
    Gerretsen M; Quak JJ; Suh JS; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
    Br J Cancer; 1991 Jan; 63(1):37-44. PubMed ID: 1989663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the biodistribution and the efficacy of monoclonal antibody 323/A3 labeled with either 131I or 186Re in human ovarian cancer xenografts.
    Kievit E; van Gog FB; Schlüper HM; van Dongen GA; Pinedo HM; Boven E
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):813-23. PubMed ID: 9240651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts.
    Pavlinkova G; Beresford GW; Booth BJ; Batra SK; Colcher D
    J Nucl Med; 1999 Sep; 40(9):1536-46. PubMed ID: 10492377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro reactivity and in vivo biodistribution of the monoclonal antibody A7 using human gastric carcinoma cell lines.
    Yamaoka N; Yamaguchi T; Otsuji E; Kato M; Kotani T; Kitamura K; Takahashi T
    Br J Cancer; 1994 Sep; 70(3):405-8. PubMed ID: 8080722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.